Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, ...

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

The longtime local news meteorologist has been temporarily absent from broadcasts as he manages his health, but he’ll be back ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

The following is a summary of “5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment ...